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Abstract 
The clinical phenotype of congenital pitu-
itary hormone deficiency is variable and can be
associated with a number of structural abnor-
malities  of  the  central  nervous  system.  We
report three Japanese patients with congenital
pituitary hormone deficiency and ophthalmo-
logical anomalies. Two of the patients initially
showed strabismus and unilateral optic nerve
hypoplasia. Thereafter, growth failure became
evident, leading to the diagnosis of pituitary
hormone  deficiency.  The  other  patient  had
severe congenital hypopituitarism with respi-
ratory distress and hypoglycemia from the first
day of life. In addition, he had prolonged jaun-
dice and impaired liver function with bilateral
optic nerve hypoplasia. Neuroimaging of the
pituitary region in all three patients demon-
strated a small anterior pituitary lobe and no
pituitary stalk. Our findings indicate that clin-
ical  variability  of  congenital  hypopituitarism
must be considered. In a patient with ophthal-
mological symptoms, endocrine evaluation and
neuroimaging of the CNS including the pitu-
itary region should be considered. 
Introduction
The anterior pituitary gland is the primary
site  of  endocrine  regulation  of  reproduction
and stress response. Congenital defects of the
pituitary  gland  can  cause  pituitary  hormone
deficiency, resulting in hypopituitarism and a
variable  clinical  phenotype.1-3 In  severe
hypopituitarism,  major  clinical  symptoms
include respiratory distress, hypotonia, hypo-
glycemia,  and  cholestatic  jaundice,  which
manifest soon after birth. Thus, early diagno-
sis and intervention for severe cases are cru-
cial  since  patients  undergo  severe  hypo-
glycemia and adrenal and thyroid insufficiency
that may affect neurological development and
survival.1-5 In mild cases, patients may be diag-
nosed  much  later  when  growth  failure
becomes prominent.1-3
Congenital hypopituitarism can be associat-
ed with a number of structural abnormalities
in the central nervous system (CNS) with oph-
thalmological  malformations.1,2 Septo-optic
dysplasia (SOD) patients may show a compli-
cation of hypopituitarism.5-8 In addition, muta-
tions of transcription factors may cause anoph-
thalamia/microophthalamia  and  hypopitu-
itarism.1,2,8-10 Here,  we  report  clinical  and
brain magnetic resonance imaging (MRI) of
three Japanese patients with congenital pitu-
itary hormone deficiency and ophthalmological
abnormalities. 
Materials and Methods  
Pituitary hormone assessment 
GH  provocative  tests  were  performed  using
insulin  (0.05  IU/kg)  and  arginine  (0.5  g/kg).
Serum  levels  of  TSH  were  determined  in
response to TRH (5 ʼg/kg). Serum cortisol was
determined  in  response  to  the  insulin  (0.05
IU/kg) tolerance test. Serum levels of LH and FSH
were determined in response to GnRH (2 ʼg/kg).
Case Reports
Case #1
The patient is an 8 year old Japanese girl.
She was born after 40 weeks gestation by nor-
mal vaginal delivery and was the first child of
nonconsanguineous parents. The patient had
no siblings, and her parents were healthy. Her
birth weight was 3290 g and length was 49 cm.
At  2  days  after  birth,  she  developed  non-
cholestatic  jaundice  and  was  treated  with
ultraviolet light for two days. At 6 months of
age, strabismus was noted. Ophthalmological
evaluation  and  computed  tomography  (CT)
revealed  right  optic  nerve  hypoplasia.  At  4
years 8 months she was referred to our hospi-
tal because of short stature. On physical exam-
ination, her height was 92.6 cm (-2.76 SD for a
normal Japanese girl) and her weight was 13.6
kg (-1.8SD for normal Japanese girl). Her psy-
chomotor  development  was  within  normal
range. 
Endocrinological evaluation is summarized
in Table 1. She had low serum levels of IGF-1
(2.75 nmol/L; normal range of 4.5-31.1 for a 3
to  5  year  old  normal  Japanese  girl),  and
impaired GH response on arginine and insulin
(0.05 IU/kg) testing. Her thyroid hormone lev-
els were low limit of normal range, suggesting
mild  central  hypothyroidism.  MRI  showed  a
hypoplastic anterior pituitary gland, no stalk,
and  an  absence  of  the  septum  pellucidum
(Figure 1A). The posterior pituitary bright spot
was not clear. Based on these findings, she
was diagnosed as having SOD. Diameters of
the optic nerve of the retrobulbar region in the
MRI at 7 years 6 months were as follows; right
was 3.04 mm and left was 6.05 mm. With the
administration  of  recombinant  human  GH,
IGF-1 levels increased to the normal range, and
the  patient  showed  successful  catch-up
growth. Regarding thyroid function after GH
replacement, we have carefully monitored.
Case #2 
The patient is now a 4 year old Japanese girl
born after 40 weeks gestation by normal vagi-
nal delivery. Her birth weight was 3000 g and
length was 48 cm. There was no family history
of growth disorders. At 3 and 5 days after birth,
she  had  non-cholestatic  jaundice  requiring
phototherapy. At 5 months of age, she showed
strabismus and was diagnosed as having right
optic nerve hypoplasia (Figure 1B). At 2 years
6  months  of  age,  she  was  referred  to  us
because  of  proportionate  short  stature.  On
admission, her height was 79.8 cm (-2.77 SD
for a normal Japanese girl) and body weight
9.5 kg (-2.0 SD for a normal Japanese girl).
She had a small anterior pituitary and ectopic
posterior pituitary (Figure 1C). Diameters of
the optic nerve of the retrobulbar region were
measured (right 3.15 mm and left 5.14 mm). 
Endocrinological findings demonstrated that
she  had  somatotroph,  corticotroph,  and  thy-
rotroph deficiencies (Table 1), and, thus, hydro-
cortisone,  L-thyroxine,  and  GH  replacement
were initiated. She presented catch-up growth
with a first-year height increment of 0.8 SDS.
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Case #3
The patient is now a 5 year old Japanese boy.
He was born to unrelated healthy parents by
normal vaginal delivery. He had no asphyxia and
his birth weight and height were 2780 g and
47.0 cm, respectively. Four hours after birth he
presented  with  apnea  and  cyanosis  and  was
found to be hypoglycemic (0.23 mmol/L). He had
a small penis (1.9 cm) and the bilateral testis
were  small  (1  mm  ﾥ 1.5  mm). The  hypo-
glycemia  disappeared  with  continuous  infu-
sion of glucose. Thereafter, he suffered from
failure  to  thrive,  cholestatic  hyperbilirubine-
mia  and  hepatomegaly.  Liver  function  tests
were altered (peak ALT 117 U/L, AST 100 U/L,
ʳ-GTP 350 U/L) and did not normalize. At 21
days  after  birth,  it  became  evident  that  his
bilateral  eyes  could  not  focus.  At  this  time,
brain  MRI  showed  bilateral  optic  nerve
hypoplasia (height of optic chiasm, 1.21 mm),
no  pituitary  stalk,  a  small  anterior  pituitary
gland, and an ectopic posterior pituitary lobe.
Endocrine  investigations  at  1  month  of  age
demonstrated deficiencies in GH, TSH, LH/FSH
and  cortisol  (Table  1).  He  was  treated  with
hydrocortisone,  L-thyroxine,  and  GH,  and
showed improvement of liver function and fail-
ure to thrive. Since treatment, he has grown
well (105.2 m, 0 SD for normal Japanese boy).
His psychomotor development is normal. 
Discussion
In this study, we report three patients with
congenital  pituitary  hormone  deficiency  and
ophthalmological abnormalities. 
Case #1 had unilateral optic nerve hypopla-
sia and an absent septum pellucidum with iso-
lated GH deficiency. She was diagnosed as hav-
ing SOD. Approximately 60% of patients with
SOD have some degree of pituitary hormone
deficiency, and the most common endocrine
defect is GH deficiency followed by TSH and
ACTH deficiency.3,5 Our case 1 showed isolated
GH  deficiency.  However,  as  other  hormone
deficiencies  may  appear  with  age,3,5 regular
evaluation of other pituitary hormones is nec-
essary.
Cases #2 and #3 had combined pituitary hor-
mone deficiency, and the degree of hypopitu-
itarism was most severe in case #3. Therefore,
case #3 showed several manifestations from
the neonatal period. Early diagnosis of hypopi-
tuitarism  in  the  neonatal  period  is  difficult
because  of  factors  such  as  prematurity  and
related neonatal complications. Indeed, it has
been  reported  that  approximately  50%  of
patients  with  congenital  pituitary  hormone
deficiency may have clinical features such as
respiratory  distress,  hypoglycemia,  hypona-
tremia, and jaundice. However, a correct diag-
nosis is made in the neonatal period in only
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Table 1. Hormone deficiency profiles of the patients
Patient （Sex） 1 (Female) 2 (Female) 3 (Male) Normal range
Age at evaluation 4.8 yr 3.6 yr 1 month
Insulin (0.05 U/kg)a
Blood glucose (mmol/L)
Before stimulation 4.71 4.44 5.10
After stimulation  2.33 2.11 2.66
GH (￿g/L)
Basal 0.28 0.36 0.78 >6.0b
Peak 1.38 1.19 2.01
Arginine (0.5 g/kg)
GH (g/L)
Basal 0.54 0.57 1.2
Peak 1.53 2.69 2.33 >6.0b
IGF-1 (mnol/L) 2.75 1.3 2.99 4.58~31.1c
2.35~19.6d
FT4 (pmol/L) 13.0 11.0 9.90 12.9~25.0
FT3 (pmol/L) 6.16 3.62 4.72 3.43~8.16
TRH (5 ʼg/kg)
TSH (mIU/L)
Basal 2.86 2.63 2.77 0.1~5.0
Peak 11.03 22.70e 26.3e 10.0~35.0
Insulin (0.05 U/kg) 
Cortsiol (nmol/L)
Basalf 217.3 223.2 129.3 138.0~551.8
Peak 300.4 268.7 245.6 275.9~965.6
GnRH (2 ￿g/kg)
LH (IU/L)
Basal 0.09 0.09 0.05 0.03~1.4
Peak 3.01 2.11 1.2 1.81~10.5
FSH (IU/L)
Basal 5.00 2.25 1.1 0.51-4.03
Peak 21.67 8.73 3.75 8.23~35.2
aThe dose of insulin (0.05 IU/kg) effectively decreased blood glucose levels in the three patients; bserum GH was determined using a recom-
binant GH standard, and, thus, the peak GH values after stimulation is less than 6 ￿g/L are used for GH deficiency; cfrom 3 to 5 year old
Japanese girl. d From 0 to 1 year old Japanese boy; etheir serum TSH levels showed delayed decline (22.7 and 26.3 mIU/L at 120 min after
TRH stimulation, respectively); fobtained at around 0800-0830 h. 
Figure 1. (A) A sagittal T1-weighted magnetic resonance image showing a small anterior
pituitary (arrow) and the absence of the septum pellucidum (arrow head) in case 1. (B) com-
puted tomography   demonstrated right optic nerve hypoplasia (arrow) in case 2. (C) A sagit-
tal T1-weighted magnetic resonance image showing a hypoplastic anterior pituitary and an
ectopic posterior lobe in case 2. (D) A sagittal T1-weighted magnetic resonance image show-
ing a hypoplastic anterior pituitary and an ectopic posterior lobe in case 3. [page 86] [Pediatric Reports 2011; 3:e20]
23% of cases.11 Therefore, congenital hypopi-
tuitarism is rare, although it is a differential
diagnosis of severe neonatal complications. 
Sobrier et al.12 have reported two patients
with a pituitary aplasia, but normally located
posterior pituitary and no optic nerve abnor-
malities.  These  two  patients  showed  severe
respiratory distress and hypoglycemia during
the  first  day  of  life.  In  these  two  patients,
mutations of HESX1 gene, which is the tran-
scription  factor  involving  pituitary  develop-
ment,  were  identified.  This  study  indicates
that  genetic  investigation  is  important  for
genetic  counseling  for  severe  congenital
hypopituitarism. Thus, the genetic causes of
our patients must be further studied.  
Prolonged jaundice is a clinical manifesta-
tion of congenital pituitary hormone deficiency.
Indirect hyperbilirubinemia is usually caused by
thyroxine deficiency. Furthermore, since corti-
sol deficiency is thought to reduce bile acid pro-
duction and flow, direct hyperbilirubinemia and
impaired liver function may occur.4,13 Thus, the
severe cortisol deficiency in case 3 can explain
impaired liver function and cholestasis. In con-
clusion,  the  clinical  variability  of  congenital
hypopituitarism must be considered in diagno-
sis. Additionally, if ophthalmological symptoms
are  observed,  endocrine  evaluation  and  neu-
roimaging of the CNS including the pituitary
region should be considered. 
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